• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Stuart J. Schnitt, MD


  • Collins LC, Achacoso N, Haque R, Nekhlyudov L, Fletcher SW, Quesenberry CP, Schnitt SJ, Habel LA.Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ.Breast Cancer Res Treat. 2013 Apr 27.
  • Aroner SA, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Rosner BA, Hankinson SE, Tamimi RM.Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies.Breast Cancer Res Treat. 2013 Apr 23.
  • Beck AH, Knoblauch NW, Hefti MM, Kaplan J, Schnitt SJ, Culhane AC, Schroeder MS, Risch T, Quackenbush J, Haibe-Kains B.Significance analysis of prognostic signatures.PLoS Comput. Biol. 2013 Jan;9(1):e1002875.
  • Schnitt SJ, Morrow M.Should intraoperative frozen section evaluation of breast lumpectomy margins become routine practice?.Am J Clin Pathol. 2012 Nov;138(5):635-8.
  • Kaplan JS, Schnitt SJ, Collins LC, Wang Y, Garber JE, Montgomery K, West RB, Krag K, Fetten K, Lincoln A, Tung NM.Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers.Am J Surg Pathol. 2012 Oct;36(10):1483-8.
  • Su X, Colditz GA, Collins LC, Baer HJ, Sampson LA, Willett WC, Berkey CS, Schnitt SJ, Connolly JL, Rosner BA, Tamimi RM.Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease.Breast Cancer Res Treat. 2012 Jul;134(2):783-91.
  • Morrow M, Harris JR, Schnitt SJ.Surgical margins in lumpectomy for breast cancer--bigger is not better.N Engl J Med. 2012 Jul 5;367(1):79-82.
  • Martins FC, De S, Almendro V, Gönen M, Park SY, Blum JL, Herlihy W, Ethington G, Schnitt SJ, Tung N, Garber JE, Fetten K, Michor F, Polyak K.Evolutionary pathways in BRCA1-associated breast tumors.Cancer Discovery. 2012 Jun;2(6):503-11.
  • Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ, Cole K, Marotti JD, Hankinson SE, Colditz GA, Tamimi RM.Androgen receptor expression and breast cancer survival in postmenopausal women.Clin Cancer Res. 2011 Apr 1;17(7):1867-74.
  • Liu Y, Tamimi RM, Collins LC, Schnitt SJ, Gilmore HL, Connolly JL, Colditz GA.The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study.Breast Cancer Res Treat. 2011 Mar 9.
  • Tamimi RM, Colditz GA, Wang Y, Collins LC, Hu R, Rosner B, Irie HY, Connolly JL, Schnitt SJ.Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer.Breast Cancer Res Treat. 2011 Jan 1.
  • Krajcovic M, Johnson NB, Sun Q, Normand G, Hoover N, Yao E, Richardson AL, King RW, Cibas ES, Schnitt SJ, Brugge JS, Overholtzer M.A non-genetic route to aneuploidy in human cancers.Nat Cell Biol. 2011 Mar;13(3):324-30.
  • Badve S, Dabbs DJ, Schnitt SJ, Baehner FL, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Rakha EA, Richardson AL, Schmitt FC, Tan PH, Tse GM, Weigelt B, Ellis IO, Reis-Filho JS.Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.Mod Pathol. 2011 Feb;24(2):157-67.
  • Lee LJ, Alexander B, Schnitt SJ, Comander A, Gallagher B, Garber JE, Tung N.Clinical outcome of triple negative breast cancer in BRCA1 mutation carriers and noncarriers.Cancer. 2011 Jan 24.
  • Alexander BM, Sprott K, Farrow DA, Wang X, D'Andrea AD, Schnitt SJ, Collins LC, Weaver DT, Garber JE.DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer.Clin Cancer Res. 2010 Dec 1;16(23):5796-804.
  • Robens J, Goldstein L, Gown AM, Schnitt SJ.Thyroid transcription factor-1 expression in breast carcinomas.Am J Surg Pathol. 2010 Dec;34(12):1881-5.
  • Tung N, Miron A, Schnitt SJ, Gautam S, Fetten K, Kaplan J, Yassin Y, Buraimoh A, Kim JY, Szasz AM, Tian R, Wang ZC, Collins LC, Brock J, Krag K, Legare RD, Sgroi D, Ryan PD, Silver D, Garber JE, Richardson AL.Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers.Breast Cancer Res. 2010 Nov 16;12(6):R95.
  • Schnitt SJ.Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics.J Natl Cancer Inst Monogr. 2010;2010(41):158-61.
  • Aroner SA, Collins LC, Schnitt SJ, Connolly JL, Colditz GA, Tamimi RM.Columnar cell lesions and subsequent breast cancer risk: a nested case-control study.Breast Cancer Res. 2010;12(4):R61.
  • Rakha EA, Reis-Filho JS, Baehner F, Dabbs DJ, Decker T, Eusebi V, Fox SB, Ichihara S, Jacquemier J, Lakhani SR, Palacios J, Richardson AL, Schnitt SJ, Schmitt FC, Tan PH, Tse GM, Badve S, Ellis IO.Breast cancer prognostic classification in the molecular era: the role of histological grade.Breast Cancer Res. 2010;12(4):207.
  • Dawood S, Hu R, Homes MD, Collins LC, Schnitt SJ, Connolly J, Colditz GA, Tamimi RM.Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study.Breast Cancer Res Treat. 2010 Aug 14.
  • Su X, Tamimi RM, Collins LC, Baer HJ, Cho E, Sampson L, Willett WC, Schnitt SJ, Connolly JL, Rosner BA, Colditz GA.Intake of fiber and nuts during adolescence and incidence of proliferative benign breast disease.Cancer Causes Control. 2010 Jul;21(7):1033-46.
  • Hilson JB, Schnitt SJ, Collins LC.Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.Am J Surg Pathol. 2010 Jun;34(6):896-900.
  • Schnitt SJ.Will molecular classification replace traditional breast pathology?.Int J Surg Pathol. 2010 Jun;18(3 Suppl):162S-166S. Review.
  • Schnitt SJ.Molecular biology of breast tumor progression: a view from the other side.Int J Surg Pathol. 2010 Jun;18(3 Suppl):170S-173S. Review.
  • Haque R, Achacoso NS, Fletcher SW, Nekhlyudov L, Collins LC, Schnitt SJ, Quesenberry CP, Habel LA.Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans.Am J Manag Care. 2010 May;16(5):351-60.
  • Schnitt SJ.Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy.Mod Pathol. 2010 May;23 Suppl 2:S60-4. Review.
  • Schnitt SJ.Clinging carcinoma: an American perspective.Semin Diagn Pathol. 2010 Feb;27(1):31-6.
  • Tung N, Wang Y, Collins LC, Kaplan J, Li H, Gelman R, Comander AH, Gallagher B, Fetten K, Krag K, Stoeckert KA, Legare RD, Sgroi D, Ryan PD, Garber JE, Schnitt SJ.Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features.Breast Cancer Res. 2010 Feb 11;12(1):R12.
  • Habel LA, Achacoso NS, Haque R, Nekhlyudov L, Fletcher SW, Schnitt SJ, Collins LC, Geiger AM, Puligandla B, Acton L, Quesenberry CP.Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.Breast Cancer Res. 2009;11(6):R85.
  • Collins LC,Martyniak AJ,Kandel MJ,Stadler ZK,Masciari S,Miron A,Richardson AL,Schnitt SJ,Garber JE.Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers.Am J Surg Pathol. 2009 Jul;33(7):1093-7.
  • Collins LC, Achacoso N, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Puligandla B, Alshak NS, Goldstein LC, Gown AM, Schnitt SJ, Habel LA.Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients.Am J Surg Pathol. 2009 Dec;33(12):1802-8.
  • Su X, Colditz GA, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Pollak MN, Rosner B, Tamimi RM.Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.Int J Cancer. 2010 Jan 1;126(1):180-90.
  • Collins LC,Wang Y,Connolly JL,Baer HJ,Hu R,Schnitt SJ,Colditz GA,Tamimi RM.Potential Role of Tissue Microarrays for the Study of Biomarker Expression in Benign Breast Disease and Normal Breast Tissue.Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):438-41.
  • Chen YY, Hwang ES, Roy R, DeVries S, Anderson J, Wa C, Fitzgibbons PL, Jacobs TW, MacGrogan G, Peterse H, Vincent-Salomon A, Tokuyasu T, Schnitt SJ, Waldman FM.Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.Am J Surg Pathol. 2009 Nov;33(11):1683-94.
  • Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, Gown A, Hammond ME, Iglehart JD, Moench S, Pierce LJ, Ravdin P, Schnitt SJ, Wolff AC.NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.J Natl Compr Canc Netw. 2009 Sep;7 Suppl 6:S1-S21; quiz S22-3. Review.
  • Nekhlyudov L,Habel LA,Achacoso NS,Jung I,Haque R,Collins LC,Schnitt SJ,Quesenberry CP Jr,Fletcher SW.Adherence to Long-Term Surveillance Mammography Among Women With Ductal Carcinoma In Situ Treated With Breast-Conserving Surgery.J Clin Oncol. 2009 Jul 1;27(19):3211-6.
  • Schnitt SJ.The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin.Breast Cancer Res. 2009;11(1):101.
  • Hu M,Peluffo G,Chen H,Gelman R,Schnitt S,Polyak K.Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast.Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3372-7.
  • Baer HJ,Collins LC,Connolly JL,Colditz GA,Schnitt SJ,Tamimi RM.Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies.Cancer. 2009 Apr 1;115(7):1404-11.
  • Hilson JB,Schnitt SJ,Collins LC.Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.Am J Surg Pathol. 2009 Feb;33(2):227-32.
  • Kleer CG,Bloushtain-Qimron N,Chen YH,Carrasco D,Hu M,Yao J,Kraeft SK,Collins LC,Sabel MS,Argani P,Gelman R,Schnitt SJ,Krop IE,Polyak K.Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression.Clin Cancer Res. 2008 Sep 1;14(17):5357-67.
  • Tamimi RM,Baer HJ,Marotti J,Galan M,Galaburda L,Fu Y,Deitz AC,Connolly JL,Schnitt SJ,Colditz GA,Collins LC.Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer.Breast Cancer Res. 2008;10(4):R67.
  • Hu M, Yao J, Carroll DK, Weremowicz S, Chen H, Carrasco D, Richardson A, Violette S, Nikolskaya T, Nikolsky Y, Bauerlein EL, Hahn WC, Gelman RS, Allred C, Bissell MJ, Schnitt S, Polyak K.Regulation of in situ to invasive breast carcinoma transition.Cancer Cell. 2008 May;13(5):394-406.
  • Schnitt SJ, Harris JR.Evolution of breast-conserving therapy for localized breast cancer.J Clin Oncol. 2008 Mar 20;26(9):1395-6.
  • Turner RR, Weaver DL, Cserni G, Lester SC, Hirsch K, Elashoff DA, Fitzgibbons PL, Viale G, Mazzarol G, Ibarra JA, Schnitt SJ, Giuliano AE.Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training.J Clin Oncol. 2008 Jan 10;26(2):258-63.
  • Collins LC, Schnitt SJ.Papillary lesions of the breast: selected diagnostic and management issues.Histopathology. 2008 Jan;52(1):20-9. Review.
  • Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW, Cibas ES, Brugge JS.A nonapoptotic cell death process, entosis, that occurs by cell-in-cell invasion.Cell. 2007 Nov 30;131(5):966-79.
  • Collins LC, Achacoso NA, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP Jr, Alshak NS, Puligandla B, Brodsky GL, Schnitt SJ, Habel LA.Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients.Mod Pathol. 2007 Nov;20(11):1149-55.
  • Harton AM, Wang HH, Schnitt SJ, Jacobs TW.p63 Immunocytochemistry improves accuracy of diagnosis with fine-needle aspiration of the breast.Am J Clin Pathol. 2007 Jul;128(1):80-5.
  • Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, Halushka MK, Sukumar S, Parker LM, Anderson KS, Harris LN, Garber JE, Richardson AL, Schnitt SJ, Nikolsky Y, Gelman RS, Polyak K.Molecular definition of breast tumor heterogeneity.Cancer Cell. 2007 Mar;11(3):259-73.
  • Harris LN, You F, Schnitt SJ, Witkiewicz A, Lu X, Sgroi D, Ryan PD, Come SE, Burstein HJ, Lesnikoski BA, Kamma M, Friedman PN, Gelman R, Iglehart JD, Winer EP.Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer.Clin Cancer Res. 2007 Feb 15;13(4):1198-207.
  • Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ.Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.Cancer. 2007 Jan 15;109(2):180-7.
  • Harris LN, Broadwater G, Lin NU, Miron A, Schnitt SJ, Cowan D, Lara J, Bleiweiss I, Berry D, Ellis M, Hayes DF, Winer EP, Dressler L.Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342.Breast Cancer Res. 2006;8(6):R66.
  • Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ.The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study.Cancer. 2006 Sep 15;107(6):1240-7.
  • Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ.Intracystic Papillary Carcinomas of the Breast: A Reevaluation Using a Panel of Myoepithelial Cell Markers.Am J Surg Pathol. 2006 Aug;30(8):1002-1007.
  • Schnitt SJ.Reporting of estrogen receptor results: back to the future?.Adv Anat Pathol. 2006 May;13(3):141.
  • Lim M, Bellon JR, Gelman R, Silver B, Recht A, Schnitt SJ, Harris JR.A prospective study of conservative surgery without radiation therapy in select patients with Stage I breast cancer.Int J Radiat Oncol Biol Phys. 2006 Jul 15;65(4):1149-54.
  • Schnitt SJ.Estrogen receptor testing of breast cancer in current clinical practice: what's the question?.J Clin Oncol. 2006 Apr 20;24(12):1797-9.
  • Bryan BB, Schnitt SJ, Collins LC.Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.Mod Pathol. 2006 May;19(5):617-21.
  • Wong JS, Kaelin CM, Troyan SL, Gadd MA, Gelman R, Lester SC, Schnitt SJ, Sgroi DC, Silver BJ, Harris JR, Smith BL.Prospective study of wide excision alone for ductal carcinoma in situ of the breast.J Clin Oncol. 2006 Mar 1;24(7):1031-6.
  • O'Malley FP, Mohsin SK, Badve S, Bose S, Collins LC, Ennis M, Kleer CG, Pinder SE, Schnitt SJ.Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast.Mod Pathol. 2006 Feb;19(2):172-9.
  • Schnall MD, Blume J, Bluemke DA, DeAngelis GA, DeBruhl N, Harms S, Heywang-Köbrunner SH, Hylton N, Kuhl CK, Pisano ED, Causer P, Schnitt SJ, Thickman D, Stelling CB, Weatherall PT, Lehman C, Gatsonis CA.Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.Radiology. 2006 Jan;238(1):42-53.
  • Baer HJ, Schnitt SJ, Connolly JL, Byrne C, Willett WC, Rosner B, Colditz GA.Early life factors and incidence of proliferative benign breast disease.Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2889-97.
  • Collins LC, Schnitt SJ.HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy.Mod Pathol. 2005 May;18(5):615-20.
  • Lehman CD, Blume JD, Weatherall P, Thickman D, Hylton N, Warner E, Pisano E, Schnitt SJ, Gatsonis C, Schnall M.Screening women at high risk for breast cancer with mammography and magnetic resonance imaging.Cancer. 2005 May 1;103(9):1898-905.
  • Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ.Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy.Cancer. 2005 May 1;103(9):1778-84.
  • Collins LC, Botero ML, Schnitt SJ.Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases.Am J Clin Pathol. 2005 Jan;123(1):16-20.
  • Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA.Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.Cancer. 2004 Oct 1;101(7):1490-500.
  • Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K.Molecular characterization of the tumor microenvironment in breast cancer.Cancer Cell. 2004 Jul;6(1):17-32.
  • Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs TW, Baer HJ, Willett WC, Colditz GA.A prospective study of diet and benign breast disease.Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1106-13.
  • Thurman SA, Schnitt SJ, Connolly JL, Gelman R, Silver B, Harris JR, Recht A.Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):152-9.
  • Fajardo LL, Pisano ED, Caudry DJ, Gatsonis CA, Berg WA, Connolly J, Schnitt S, Page DL, McNeil BJ,.Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.Acad Radiol. 2004 Mar;11(3):293-308.
  • Elkin EB, Weinstein MC, Winer EP, Kuntz KM, Schnitt SJ, Weeks JC.HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis.J Clin Oncol. 2004 Mar 1;22(5):854-63.
  • Collins LC, Connolly JL, Page DL, Goulart RA, Pisano ED, Fajardo LL, Berg WA, Caudry DJ, McNeil BJ, Schnitt SJ.Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial.Am J Surg Pathol. 2004 Jan;28(1):126-31.
  • Baer HJ, Schnitt SJ, Connolly JL, Byrne C, Cho E, Willett WC, Colditz GA.Adolescent diet and incidence of proliferative benign breast disease.Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1159-67.
  • Schnitt SJ.Risk factors for local recurrence in patients with invasive breast cancer and negative surgical margins of excision. Where are we and where are we going?.Am J Clin Pathol. 2003 Oct;120(4):485-8.
  • Schnitt SJ.The diagnosis and management of pre-invasive breast disease: flat epithelial atypia--classification, pathologic features and clinical significance.Breast Cancer Res. 2003;5(5):263-8.
  • Schnitt SJ.Benign breast disease and breast cancer risk: morphology and beyond.Am J Surg Pathol. 2003 Jun;27(6):836-41.
  • Schnitt SJ, Vincent-Salomon A.Columnar cell lesions of the breast.Adv Anat Pathol. 2003 May;10(3):113-24.
  • Porter D, Lahti-Domenici J, Keshaviah A, Bae YK, Argani P, Marks J, Richardson A, Cooper A, Strausberg R, Riggins GJ, Schnitt S, Gabrielson E, Gelman R, Polyak K.Molecular markers in ductal carcinoma in situ of the breast.Mol Cancer Res. 2003 Mar;1(5):362-75.
  • Byrne C, Webb PM, Jacobs TW, Peiro G, Schnitt SJ, Connolly JL, Willett WC, Colditz GA.Alcohol consumption and incidence of benign breast disease.Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1369-74.
  • Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Harris JR, O'Malley F, Schnitt SJ, Singletary SE, Winchester DP, , , ,.Standard for the management of ductal carcinoma in situ of the breast (DCIS).CA Cancer J Clin. 2002 Sep-Oct;52(5):256-76.
  • Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Giuliano A, Harris JR, O'Malley F, Schnitt SJ, Singletary SE, Winchester DP, , , ,.Standard for breast conservation therapy in the management of invasive breast carcinoma.CA Cancer J Clin. 2002 Sep-Oct;52(5):277-300.
  • Jacobs TW, Connolly JL, Schnitt SJ.Nonmalignant lesions in breast core needle biopsies: to excise or not to excise?.Am J Surg Pathol. 2002 Sep;26(9):1095-110.
  • Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs T, Peiro G, Willett W, Colditz GA.Family history of breast cancer, age and benign breast disease.Int J Cancer. 2002 Jul 20;100(3):375-8.
  • Schnitt SJ.Benign breast disease and breast cancer risk: potential role for antiestrogens.Clin Cancer Res. 2001 Dec;7(12 Suppl):4419s-4422s; discussion 4.
  • Jacobs TW, Schnitt SJ, Tan X, Brown LF.Radial scars of the breast and breast carcinomas have similar alterations in expression of factors involved in vascular stroma formation.Hum Pathol. 2002 Jan;33(1):29-38.
  • Khalkhali I, Baum JK, Villanueva-Meyer J, Edell SL, Hanelin LG, Lugo CE, Taillefer R, Freeman LM, Neal CE, Scheff AM, Connolly JL, Schnitt SJ, Houlihan MJ, Sampalis JS, Haber SB.(99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study.Radiology. 2002 Jan;222(1):149-55.
  • Enerbäck C, Porter DA, Seth P, Sgroi D, Gaudet J, Weremowicz S, Morton CC, Schnitt S, Pitts RL, Stampl J, Barnhart K, Polyak K.Psoriasin expression in mammary epithelial cells in vitro and in vivo.Cancer Res. 2002 Jan 1;62(1):43-7.
  • Schnitt SJ.Traditional and newer pathologic factors.J Natl Cancer Inst Monogr. 2001(30):22-6.
  • Schnitt SJ, Jacobs TW.Current status of HER2 testing: caught between a rock and a hard place.Am J Clin Pathol. 2001 Dec;116(6):806-10.
  • Krop IE, Sgroi D, Porter DA, Lunetta KL, LeVangie R, Seth P, Kaelin CM, Rhei E, Bosenberg M, Schnitt S, Marks JR, Pagon Z, Belina D, Razumovic J, Polyak K.HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9796-801.
  • Lehr HA, Jacobs TW, Yaziji H, Schnitt SJ, Gown AM.Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis.Am J Clin Pathol. 2001 Jun;115(6):814-22.
  • Pisano ED, Fajardo LL, Caudry DJ, Sneige N, Frable WJ, Berg WA, Tocino I, Schnitt SJ, Connolly JL, Gatsonis CA, McNeil BJ.Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V.Radiology. 2001 Jun;219(3):785-92.
  • Siziopikou KP, Schnitt SJ, Connolly JL, Hayes DF.Detection and Significance of Occult Axillary Metastatic Disease in Breast Cancer Patients.Breast J. 1999 Jul;5(4):221-229.
  • Siziopikou KP, Schnitt SJ.MIB-1 Proliferation Index in Ductal Carcinoma In Situ of the Breast: Relationship to the Expression of the Apoptosis-Regulating Proteins bcl-2 and p53.Breast J. 2000 Nov;6(6):400-406.
  • Janov AJ, Tulecke M, O'Neill A, Lester S, Mauch PM, Harris J, Schnitt SJ, Shapiro CL.Clinical and pathologic features of breast cancers in women treated for Hodgkin's disease: a case-control study.Breast J. 2001 Jan-Feb;7(1):46-52.
  • Schnitt SJ.Breast cancer in the 21st century: neu opportunities and neu challenges.Mod Pathol. 2001 Mar;14(3):213-8.
  • Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ.Pathologic features of breast cancers in women with previous benign breast disease.Am J Clin Pathol. 2001 Mar;115(3):362-9.
  • Jacobs TW, Pliss N, Kouria G, Schnitt SJ.Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization.Am J Surg Pathol. 2001 Feb;25(2):229-36.
  • Khalkhali I, Villanueva-Meyer J, Edell SL, Connolly JL, Schnitt SJ, Baum JK, Houlihan MJ, Jenkins RM, Haber SB.Diagnostic accuracy of 99mTc-sestamibi breast imaging: multicenter trial results.J Nucl Med. 2000 Dec;41(12):1973-9.
  • Byrne C, Connolly JL, Colditz GA, Schnitt SJ.Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk.Cancer. 2000 Nov 15;89(10):2046-52.
  • Wong JS, O'Neill A, Recht A, Schnitt SJ, Connolly JL, Silver B, Harris JR.The relationship between lymphatic vessell invasion, tumor size, and pathologic nodal status: can we predict who can avoid a third field in the absence of axillary dissection?.Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):133-7.
  • Galper S, Recht A, Silver B, Bernardo MV, Gelman R, Wong J, Schnitt SJ, Connolly JL, Harris JR.Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy.Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):125-32.
  • Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ.Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999.Arch Pathol Lab Med. 2000 Jul;124(7):966-78.
  • Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ.Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence.J Clin Oncol. 2000 Apr;18(8):1668-75.
  • Peiro G, Bornstein BA, Connolly JL, Gelman R, Hetelekidis S, Nixon AJ, Recht A, Silver B, Harris JR, Schnitt SJ.The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy.Breast Cancer Res Treat. 2000 Jan;59(1):49-54.
  • Abner AL, Connolly JL, Recht A, Bornstein B, Nixon A, Hetelekidis S, Silver B, Harris JR, Schnitt SJ.The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy.Cancer. 2000 Mar 1;88(5):1072-7.
  • Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ.HER-2/neu protein expression in breast cancer evaluated by immunohistochemistry. A study of interlaboratory agreement.Am J Clin Pathol. 2000 Feb;113(2):251-8.
  • Morrow M, Schnitt SJ.Treatment selection in ductal carcinoma in situ.JAMA. 2000 Jan 26;283(4):453-5.
  • Hetelekidis S, Schnitt SJ, Silver B, Manola J, Bornstein BA, Nixon AJ, Recht A, Gelman R, Harris JR, Connolly JL.The significance of extracapsular extension of axillary lymph node metastases in early-stage breast cancer.Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):31-4.
  • Gertig DM, Stillman IE, Byrne C, Spiegelman D, Schnitt SJ, Connolly JL, Colditz GA, Hunter DJ.Association of age and reproductive factors with benign breast tissue composition.Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):873-9.
  • Sharifi S, Peterson MK, Baum JK, Raza S, Schnitt SJ.Assessment of pathologic prognostic factors in breast core needle biopsies.Mod Pathol. 1999 Oct;12(10):941-5.
  • Jacobs TW, Silverman JF, Schroeder B, Raza S, Baum JK, Schnitt SJ.Accuracy of touch imprint cytology of image-directed breast core needle biopsies.Acta Cytol. 1999 Mar-Apr;43(2):169-74.
  • Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, Lester S, Lyons JA, Harris JR, Schnitt SJ.Predictors of local recurrence following excision alone for ductal carcinoma in situ.Cancer. 1999 Jan 15;85(2):427-31.
  • Jacobs TW, Byrne C, Colditz G, Connolly JL, Schnitt SJ.Radial scars in benign breast-biopsy specimens and the risk of breast cancer.N Engl J Med. 1999 Feb 11;340(6):430-6.
  • Jacobs TW, Siziopikou KP, Prioleau JE, Raza S, Baum JK, Hayes DF, Schnitt SJ.Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor?.Mod Pathol. 1998 Mar;11(3):259-64.
  • Guidi AJ, Schnitt SJ, Fischer L, Tognazzi K, Harris JR, Dvorak HF, Brown LF.Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast.Cancer. 1997 Nov 15;80(10):1945-53.
  • Jacobs TW, Prioleau JE, Stillman IE, Schnitt SJ.Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer.J Natl Cancer Inst. 1996 Aug 7;88(15):1054-9.
  • Schnitt SJ, Harris JR, Smith BL.Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet?.Cancer. 1996 Jun 1;77(11):2189-92.
  • Bodis S, Siziopikou KP, Schnitt SJ, Harris JR, Fisher DE.Extensive apoptosis in ductal carcinoma in situ of the breast.Cancer. 1996 May 1;77(9):1831-5.
  • Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J, Schnitt S, Livingston DM.Location of BRCA1 in human breast and ovarian cancer cells.Science. 1996 Apr 5;272(5258):123-6.
  • Schnitt SJ, Hayman J, Gelman R, Eberlein TJ, Love SM, Mayzel K, Osteen RT, Nixon AJ, Pierce S, Connolly JL, Cohen P, Schneider L, Silver B, Recht A, Harris JR.A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer.Cancer. 1996 Mar 15;77(6):1094-100.
  • Siziopikou KP, Prioleau JE, Harris JR, Schnitt SJ.bcl-2 expression in the spectrum of preinvasive breast lesions.Cancer. 1996 Feb 1;77(3):499-506.
  • Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ.Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer.Hum Pathol. 1995 Jan;26(1):86-91.
  • Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, Eberlein TJ, Mayzel K, Silver B, Harris JR.The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy.Cancer. 1994 Sep 15;74(6):1746-51.
  • Nixon AJ, Neuberg D, Hayes DF, Gelman R, Connolly JL, Schnitt S, Abner A, Recht A, Vicini F, Harris JR.Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer.J Clin Oncol. 1994 May;12(5):888-94.
  • Guidi AJ, Fischer L, Harris JR, Schnitt SJ.Microvessel density and distribution in ductal carcinoma in situ of the breast.J Natl Cancer Inst. 1994 Apr 20;86(8):614-9.
  • Schnitt SJ, Goldwyn RM, Slavin SA.Mammary ducts in the areola: implications for patients undergoing reconstructive surgery of the breast.Plast Reconstr Surg. 1993 Dec;92(7):1290-3.
  • Schnitt SJ, Jimi A, Kojiro M.The increasing prevalence of benign proliferative breast lesions in Japanese women.Cancer. 1993 Apr 15;71(8):2528-31.
  • Schnitt SJ, Connolly JL, Tavassoli FA, Fechner RE, Kempson RL, Gelman R, Page DL.Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria.Am J Surg Pathol. 1992 Dec;16(12):1133-43.
  • Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL.Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.Hum Pathol. 1992 Sep;23(9):974-9.
  • London SJ, Connolly JL, Schnitt SJ, Colditz GA.A prospective study of benign breast disease and the risk of breast cancer.JAMA. 1992 Feb 19;267(7):941-4.
  • Schnitt SJ, Connolly JL, Recht A, Silver B, Harris JR.Influence of infiltrating lobular histology on local tumor control in breast cancer patients treated with conservative surgery and radiotherapy.Cancer. 1989 Jul 15;64(2):448-54.
  • Schnitt SJ, Silen W, Sadowsky NL, Connolly JL, Harris JR.Ductal carcinoma in situ (intraductal carcinoma) of the breast.N Engl J Med. 1988 Apr 7;318(14):898-903.
  • Schnitt SJ, Connolly JL, Khettry U, Mazoujian G, Brenner M, Silver B, Recht A, Beadle G, Harris JR.Pathologic findings on re-excision of the primary site in breast cancer patients considered for treatment by primary radiation therapy.Cancer. 1987 Feb 15;59(4):675-81.
  • Recht A, Silver B, Schnitt S, Connolly J, Hellman S, Harris JR.Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage.Int J Radiat Oncol Biol Phys. 1985 Jul;11(7):1271-6.
  • Schnitt SJ, Connolly JL, Harris JR, Cohen RB.Radiation-induced changes in the breast.Hum Pathol. 1984 Jun;15(6):545-50.
  • Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RB.Pathologic predictors of early local recurrence in Stage I and II breast cancer treated by primary radiation therapy.Cancer. 1984 Mar 1;53(5):1049-57.